The global syndrome therapeutics market size was valued at US$ 147.4 Mn in 2024 and is projected to reach US$ 407.3 Mn by ...

FDA label expansion makes selumetinib the second MEK inhibitor approved for adults with neurofibromatosis type 1-associated ...

Novo Nordisk (NVO) is deeply undervalued after a 43% YTD decline, despite strong fundamentals and global obesity market ...

By implementing an automated 3D cell segmentation process, researchers mapped neurons and muscle fibers at the single-cell ...

LTIMindtree deepens its Microsoft Azure partnership to drive AI-led transformation, boost productivity, and deliver secure ...

Lifeway Foods achieved significant revenue growth since mid-2024, showcasing resilience despite internal family drama. Read ...

The region is projected to post earnings-per-share growth of 8.4% annually ahead of Southeast Asia, China, emerging Europe ...

A bold US expansion and renewed spending are testing investor faith in Xero's long-term growth story, as its shares slip by ...

The global sarcopenia treatment market, valued at approximately USD 3.07 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.48% over the forecast period from 2024 to ...

The Hershey Company has completed its acquisition of organic snack brand LesserEvil. A move which expands the US ...

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 ...

Dutch Bros has a big opportunity as it introduces hot food items and continues its expansion. With 2025 beginning to wind down, it's time for investors to start looking toward what could be the best ...